CSL Signs Licensing Deal with Eli Lilly for Clazakizumab to ...

Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug

CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. The post Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug appeared first on MedCity News.

Lilly to pay CSL $100M to license monoclonal antibody targeting IL-6

The Australian company will retain rights for an end-stage kidney disease indication currently being tested in a Phase 3 trial while Lilly explores other uses.

CSL signs licensing deal with Eli Lilly for clazakizumab to ...

Lilly licenses CSL’s IL-6 immuno-inflammatory antibody for $100M upfront

CSL will need more than $100 million to recover from its current difficulties, but it’s a start. Eli Lilly has paid the nine-figure sum upfront for rights to the Australian company’s anti ...

CSL stock price ends higher after Eli Lilly clazakizumab deal, with buyback in the background

CSL Ltd shares rose as much as 2.1% Wednesday after announcing a $100 million licensing deal with Eli Lilly for the kidney drug clazakizumab. CSL closed up 0.78% at A$152.74. The company also bought back 50,829 shares Tuesday, bringing total repurchases to over 3.2 million. The ASX200 index edged up 0.16%. The post CSL stock price ends higher after Eli Lilly clazakizumab deal, with buyback in the background appeared first on TechStock².

Lunch Wrap: Big banks and CSL light up as ASX edges higher

ASX edges higher as banks do the heavy lifting NAB jumps 5% to record highs after $2bn quarter CSL gains on US$100m Eli Lilly licensing deal   Australia’s earnings season kept the ASX in positive territory at lunchtime in the eastern states, with big banks and CSL doing the heavy lifting. Around 1pm (AEDT) the ASX 200 was up 25.60 points or 0.29% to 8984.50 points. Overnight in the US, markets were largely flat after returning from the President…